Abstract -The chemical structure and the pharmacokinetics of a compound influence not only the sensitivity and specificity requirements of the assay, but also the most suitable biological specimen for its quantitation.
Introduction
Therapuetic drug monitoring can involve quantitation in the microgram (10-6 gm or ppm), nanogram (10-9 gm or ppb) or picogram (10-12 gm or ppt) concentration range. These concentrations are present in a complex biological matrix (whole blood/urine/tissue) from which it must be selectively extracted and "cleaned up" prior to quantitation, Schill, (1).
The chemical structure of a compound influences the analytical method best suited to its quantitation, while the ionizable groups in the molecule determine its acid/base character (pKa), and its extractability, de Silva (2) . The dose administered (mg/kg), the bioavailability of the dosage form, and the pharmacokinetic profile of the drug govern the absolute concentrations of the parent drug and/or metabolites to be quantitated, Kaplan and Jack (3), Schwartz and de Silva (4) . These criteria influence the ultimate sensitivity and specificity required of the analytical method, de Silva (5) , and the type of biological medium best suited for analysis, i.e. whole blood, plasma or urine, de Silva (6).
The degree of "clean up" required is dependent on the analytical method used (GLC, TLC, HPLC) and on the tolerance of the specific type of detection system to contamination. The options available for processing a biological specimen must be tailored not only to the analytical method itself, but also to the sensitivity and specificity required of it, (6). Factors responsible for compound losses during sample preparation (adsorption, stability) are critical at low concentrations and may adversly affect the reliability of an assay. Consequently, maximizing the overall recovery of the assay is essential not only for sensitivity but also for good precision and accuracy.
The armentarium of sensitive and specific methods currently available to the analyst is quite 
I. Chemical Structure and Analytical Utility
Chemical manipulation of a drug via derivatization enhances the sensitivity and the specificity of the assay, Lawrence and Frei (7), Blau and King (8) , and has certain advantages even if the intrinsic sensitivty is adequate and/or blood concentration is not a limiting factor. The sample volume extracted can be reduced from milliliter to microliter amounts, and/or the aliquot of the final residue analyzed can be reduced by sample dilution, significantly improving chromatographic analysis by minimizing endogenous interferences, resulting in more acurate, reproducible and reliable quantitation. All of the above factors should be optimized in the overall development of a reliable and validated method for eventual therapeutic drug monitoring.
The intrinsic properties of the l,4-benzodiazepines/2-ones and imidazobenzodiazepines enables quantitation by EC-GC or GC-CI-MS due to the electro-negative groups (7 Halo or Nitro) and the amide function (>Nl-C') in the diazepine ring and by HPLC using either UV (254 nm) or electrochemical detection by differential pulse polarography of the azomethine (>C5= N4 -) group in the molecule, de Silva (9).
Imidazo-1,4-benzodiazepine,. carboxamide, a potent anxiolytic agent is administered in doses as low as 0.1-0.2 mg/70 kg adult. Direct analysis by EC-GLC was unsuccessful due to its high m.p.> 350° and resulted in broad peaks with poor sensitivity. A sensitive and specific GC-NCI-MS assay was developed by converting the compound into a volatile nitrile derivative by reacting the amide group with pentafluoropropionic anhydride in trimethylamine with a sensitivity of 100 pg/mi of plasma ( Figure 2 ). Guanidine compounds are difficult to analyze at low concentrations due to their high polarity.
Guanfacine, a new antihypertensive agent and its 3-hydroxy metabolite were analyzed by EC-GLC with high sensitivity by reaction of the guanidine group with hexafluororacetyl acetone to form a triazine derivative. The NH and OH groups in the molecule were methyiated with CH3I by extractive alkylation ( Figure 4 ). This volatile complex derivative was determined in urine by EC-GLC with good sensitivity (25 ng/mi).
A comparison of chromatography using packed vs. capillary columns is shown in Figure 5 , Guerret et al (11) . Chromatograms (EC-GLC) of a 0-24 hr urine extract from a subject given a 2 mg oral dose of Guanfacine a) patient sample extract, b) patient "control" sample both on a packed column and c) patient sample extract on a capillary column.
Microderivatization of a drug at low concentrations can be problematic in obtaining reproducible yields and in minimizing adsorption losses. Prostaglandin drugs, e.g. the antiulcer agent, Trimoprostiladministered in ig/kg doses results in plasma concentrations in the picogram range.
GC-NCI-MS analysis of the drug as its-OTMS, Pentafluorobenzyl ester enabled its sensitive and specific quantitation with a limit of 100 pg/mi of plasma, Mm et al (12) . Endogenous prostaglandins have likewise been determined using both capillary EC-GLC and capillary GC-MS analysis, Chiabrando et al (13) .
III.
Pharmacokinetic Factors Which Influence Sample Preparation
A. Biotransformation
Metabolic studies on the "in vitro" biotransformation of a compound using microsomal (9000 x g) enzyme preparations and/or "in vivo" studies using radioisotopically labelled (14C, 3H) compound should be underway in parallel with method development.
Determination of the "total" radioactivity in plasma or urine vs. solvent extractable radioactivity will indicate the extent to which polar non-extractable metabolites are present.
Chromatographic analysis (TLC or HPLC) of the solvent extractable fraction using either a radiochromatogram scanner or a radiometric detector with HPLC analysis will indicate the relative amounts of the parent drug and any metabolites present; a reliable index of the specificity of the extraction procedure (pH and solvent used).
Characterization of the chemical structure of the predominant (key) Phase I metabolites using GC-MS, NMR and the synthesis of authentic reference compounds will enable their quantitation in biological fluids using sensitive and specific chemical methods, Gorrod and Beckett (14).
Chromatographic analysis is necessary to ensure the specificity of analysis for the parent drug and/or any major metabolites present. Any "first pass" biotransformation will be reflected 
IV. Sample Collection Devices
The type of collection device into which the biological sample is drawn should be evaluated as part of method development for a specific drug and its metabolites. The selection of glass or plastic tubes for blood collection and subsequent separation of plasma or serum and its effect on the drug in an "in vivo" sample with respect to adsorption losses, contamination by plasticizers The degree of sample preparation and "clean up" required is usually a function of the analytical method to be used and the tolerance of the specific detection system to contamination.
The options available for processing whole blood/plasma/tissue homogenate or proteolytic digest are outlined in Figure 6 .
The biological specimen undergoes a protein precipitation step, followed by pH adjustment and selective extraction into a suitable solvent, which can then be processed in one of several ways depending on the analytical method to be used, de Silva, (17).
B.
Analysis of Urine and Feces
A flow diagram for the extraction of urine and feces is outlined in Figure 7 .
The analysis of these two media requires an aliquot of a representative sample, i.e., an aliquot from a total voidance collected over a known excretion period (e.g., 24, 48 hrs.). The sample is filtered to remove particulates and analyzed for the "free" or directly extractable and "bound" or conjugated fractions of drug and metabolites present.
Basic extracts of urine or feces are not as heavily contaminated with endogenous Depending on the determinate step, the residue of the final extract (blood, plasma, tissue, urine or feces) may have to be derivatized (silylation of hydroxyl groups, esterification of Extraction of the analyte usually involves either organic solvent extraction at a pH at which the analyte is >99% unionized (basic drugs at pH >6, and acid drugs at pH <5. was used to analyze several anticonvulsants from serum using 100 iil to 2 ml of sample (depending on concentration) with recovery> 90%. The extracts were analyzed by reverse phase HPLC and correlated well against GLC and EMIT analysis. A variety of adsorbant cartridges (e.g. ion exchange resins, reverse phase (C18) packing), makes it a viable procedure, Williams and Viola (20) .
Solid extraction columns containing C18 packings (e.g. Bond Elutfrom Analytichem International, USA) contained in polyethylene hypodermic syringes with luerlock fittings (1 ml capaicty) are convenient for batchwise manual use. Small sample volumes (< 5OOil) of blood, plasma or serum are passed through the column, which retains the analyte, which is later stripped off with a suitable eluent, and readily reconstituted in 25- Ingenuity is required in the chemical synthesis of the hapten to ensure specificity to the major portion of the parent molecule in order that the antibody produced can distinguish it in the presence of its major metabolites as shown in Figure 9 for clonazepam.
Radioimmunoassays for benzodiazepines, Dixon (27) , are particularly useful in monitoring pediatric patients on anticonvulsant therapy which usually involves multiple drug regimens and the need for small (jil) sampling techniques. Dixon and Crews (28) 
without any specific storage precautions. The drugs was subsequently leached with 1 ml of phosphate buffered saline and analyzed directly by RIA. The technique is readily amenable for toxicological overdosage/drug compliance screening and for other clinical monitoring needs.
2.
Radioreceptor Assays (RRA)
This new biological assay technique resulted from the pharmacologists search for specific binding sites or receptors in the brain for benzodiazepines which might differentiate the anxiolytic from sedative properties of these compounds, and has been reviewed by Dubnick et al (29) . Radioreceptor assays for specific benzodiazepines have also been reported by Skolnick et al (30) , and are being used to quantitate the total "active" fraction of parent drug and pharmacologically active metabolites in pharmacodynamic studies.
VII.
Chromatographic Techniques

A. Analysis by GLC
Although analysis of the intact molecular moiety (underivatized) is preferred to ensure specificity, derivatization is often necessary for valid analytical reasons. Simple derivatization reactions such as extractive alkylation and/or silylation can be used where needed, to yield very sensitive, specific and readily automatable methods. The idiosyncrasies of specific detectors such as the ECD and the N/P-D have to be considered during sample preparation so as not to introduce contaminants into the extract which could be detrimental.
The N/P selective detector, for example, is susceptible to severe interference by residues of silylating reagents and from phosphate plasticizers contained in plastic syringes and blood collection tubes which leach into the biological sample and are co-extracted. Thus, the selection of the proper type of syringe and collection tubes become a necessary part of the assay development program and should be evaluated with forethought so as not to jeopardize the clinical studies for which the assay is intended.
Where high sensitivity and resolution is required, GLC analysis using either the electron capture (ECD) or Nitrogen Specific (N/P-D) detector in conjunction with fused silica capillary columns is the "state of the art" in GLC analysis, and with GC-MS/SIM analysis. Fully automated GLC analysis from sample injection to final data reduction is now the generally accepted mode of analysis. Capillary fused silica columns used in conjunction with the N/P-D have found extensive application in monitoring tricyclic antidepressants (TCDs) with high sensitivity and specificity. Since numerous metabolites are commonly found at steady state especially with multiple drug therapy, the high resolution of the capillary column is essential.
The small sample volume usually injected (1 p1 or less) is a trade off to prevent column overload.
The N/P-D is stable even when the electrometer is operated at maximum sensitivity, as reported by van Brunt (31).
EC-GLC analysis has been extensively used in the determination of the l,4-benzodiazepines (which are widely used in clinical practice as antianxiolytics, muscle relaxants, hypnotics, and GC-NCI-MS analysis of the 1, 4-benzodiazepin-2-ones has inherently high sensitivity associated with negative ion formation by electron capture in the CI source which can be 100- 
C. Analysis by Thin Layer Chromatography
Thin layer chromatographic (TLC) analysis enables rapid devlopment of chromatographic parameters for eventual use in HPLC analysis. Preliminary separation of a drug/metabolites using radiolabelled compound enables qualitative identification via radiochromatographic scanning or autoradiography to isolate metabolites from either an "in vitro" 9000 x g microsomal incubation or from "in vivo" biotransformation studies (14). The separated compounds can be eluted from the silica gel and analyzed by a variety of selective techniques, e.g.,spectrophoto/fluorometry, polarography, GLC, GC-MS, NMR, not only for quantitation but also for structure elucidation purposes.
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Quantitative analysis by "in situ" spectrophoto/flurometry has been extensively utilized, especially since the advent of high performance TLC using small sample aliquots 1 jil or less applied to the chromatoplate, rapid development and densitometric analysis, Fenimore (39) . The sensitivity and specificity of the technique is especially useful in the fluorescence mode and was used in the analysis of flurazepam and its major metabolites in plasma as their highly fluorescent 9-acridanone derivatives. These were extracted, separated by TLC and quantitated by "in situ"spectrofluorodensitometry ( Figure 12 HPLC analysis has several advantages that can be collectively optimized for sensitive and specific detection. Two modes of operation, normal phase (adsorption) and reverse phase (partition) are the most widely used for drug analysis, although cation/anion exchange chromatography is also used for highly polar zwitterionic drug molecules such as the -lactam antibiotics and quarternary (NH) compounds. Drug molecules can be analyzed either as the intact moiety or as a suitable derivative using either U.V., fluorescence or electrochemical detection. HPLC is uniquely suited to the analysis of thermally unstable compounds, (e.g. the benzodiazepines chiordiazepoxide and its metabolites), and amphoteric "zwitterionic" compounds (antibiotics) which are difficult to extract, at best. Plasma and serum can be analyzed directly following protein precipitation with acetonitrile, injecting an aliquot of the protein free filtrate (pff) (after partitioning with n-hexane as a clean up step to remove colloidal lipids), Blanchard (41) . Urine is filtered to remove salts and colloidal materials, and an aliquot diluted in the mobile phase and analyzed directly using reverse phase HPLC.
Amoxicillin; [a lactam antibiotic, (pKa= 2.4, 9.6) structurally related to ampicillin], and its benzyl-penicilloic acid, were analyzed directly in urine, by HPLC using fluorometric detection following post column derivatization with fluorescamine, Lee et al (42), (Figure 13 ). High sensitivity and specificity can be achieved by tandem monitoring of the column effluent using either UV/fluorescence or UV/Electrochemical detection. The use of an electrochemical detector for the determination of benzodiazepines in the reduction mode using a dropping mercury electrode (DME), Hackman and Brooks (43) Electrochemical detectors have also found extensive application in HPLC analysis in the oxidative mode using a glassy carbon electrode especially in the analysis of catecholamines with excellent sensitivity in the picogram concentration range, Grossman (44) . The oxidative detector is very low cost compared to UV, fluorescence or polarographic detectors, and its sensitivity has advanced the field of catecholamine biochemistry significantly. Whereas EC-GLC or GC-MS analysis requires derivatization of the phenolic and amine groups using silylating and perfluoro acylating agents, HPLC analysis can achieve the same sensitivity of 5-10 pg/ml using the electrochemical detector in the phenolic group specific oxidative mode, Baker and Coutts (45) .
A variety of cell geometries used in solid state carbon electrodes (tubular, thin layer and rotating disc) and dropping mercury electrodes (DME) types have been reviewed by Hanekamp et al. (46) . HPLC analysis has made very significant inroads into therapeutic drug monitoring which was once the monopoly of GLC, TLC or direct spectrophometric methods. The popularity of the technique is due largely to its versatility in the variety of modes of operation, i.e. reversed Although normal phase HPLC is still popular, the limitations of the column packing (silica) and the organic mobile phases required restricts its utility. Reversed phase HPLC has emerged as the predominant technique especially in therapeutic drug monitoring, since all the available detectors are compatible with the aqueous mobile phases used with the variety of column packings available. Automatability of HPLC has reached a high degree of sophistication. In addition to its ability to analyze either organic solvent extracts or a protein free filtrate (pff), column switching techniques using "pre columns" placed before the analytical column has enabled direct injection of the biological sample (blood/plasma/serum/saliva/urine)directly on the analytical system. The sample is introduced onto the precolumn which retains the analyte, flushing the lipids out to waste. After flushing the precolumn to further clean up the sample, the analyte is back flushed or stripped from the precolumn and moved onto the analytical column for eventual quantitation using either U.V./fluorescence/electrochemical detection. The entire process is under microprocessor control from initial sample introduction to final data reduction/reporting, hence represents a truly fully automated system.
Trace enrichment methods for drug analysis have been described for segmented Technicon©"Fast LC" systems by Dolan et al (47) and involves organic solvent extraction, phase separation, an "evaporation to dryness (EDM) module which deposits the solvent sample residue on a moving teflon belt from which the residue is redissolved in the mobile phase for HPLC analysis. Analysis of theophylline and four anticonvulsants, primidone, phenobarbital, phenytoin, carbamazepine and their active metabolites is performed in the system with U.V. monitoring at 270 nm.
In contrast to the segmented system, is the direct analysis of the biological sample without solvent extraction by employing column switching techniques to effect trace enrichment of the analyte on a precolumn prior to elution onto the analytical column for eventual quantitation. A fully automated HPLC system for drug monitoring by direct injection of plasma/saliva/urine was first described by Roth et al. (48) . The system consists of a programmable automatic sampling WISP©unit connected via two alternating precolumns for sample enrichment into the analytical column (all containing reverse-phase C-packing) for eventual quantitation by fluorometric detection. The system was reported to have high precision (C.V. = 1.4%), and excellent stability with an inter-assay precision ranging from 3-5% (C.V). The volume of biological sample injected varied from 10-150 il depending on the medium used. The chromatograms obtained are extremely "clean" containing only trace amounts of endogenous compounds in addition to the analyte(s) which predominate in the analytical "midcut" processed. The system offers the advantages of minimal sample handling, combined with automated 24 hour unattended operation for high sample throughput.
Automated sample clean up in HPLC using column switching techniques was recently reviewed by Karger et al. (49) .
HPLC analysis using post column reaction detection is another viable means of quantitation of an analyte with enhanced sensitivity and specificity. Werkhoven-Goewie et al. (50) described the automated determination of Secoverine in blood after enzymatic hydrolysis with subtilisin-A to release protein-bound drug using pre-column switching for analyte enrichment followed by post-column paired ion reaction with dimethoxyanthracene sulfonate for fluorometric determination. The system could be readily adapted for the quantitation of glucuronide/sulfate conjugates of drugs in urine as their aglycones.
Post-column detection by photochemical reaction by U.V. irradiation to yield fluorescent products is another novel applIcation described by Birksand Frei (51) . A photochemical reactor using a medium or high pressure arc lamp (Hg, Xe or Xe-Hg) as the U.V. source was used to convert a variety of drug analytes; e.g., Vitamin K, Clobazam and its desmethyl metabolite, demoxepam, and phenothiazenes-mesoridazine, thioridazine, sulforidazine into photochemically irradiated fluorescent products for quantitation with nanogram sensitivity.
Post-column derivatization techniques available for HPLC analysis were recently reviewed by Stewart (52) .
Microbore HPLC like its counterpart capillary GLC is very promising due to its high resolution capacity which could be advantageous in the simultaneous analysis of several analytes The chemical structure and the pharmacokinetics of a compound influence not only the sensitivity and specificity requirements of the assay, but also the most suitable biological specimen for its quantitation. The criteria to be used in sample preparation and the analytical method selected for quantitation should aim to optimize all of the above factors in the eventual development of a reliable and validated method for the compound suitable for use in clinical therapeutic monitoring, Sadee and Beelen (58) .
